Two Sigma Investments, LP Annovis Bio, Inc. Put Options Transaction History
Two Sigma Investments, LP
- $50.6 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ANVS
# of Institutions
50Shares Held
1.82MCall Options Held
102KPut Options Held
98.3K-
Vanguard Group Inc Valley Forge, PA697KShares$1.93 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$507,7040.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA165KShares$455,8250.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$278,9630.0% of portfolio
-
Merit Financial Group, LLC91.3KShares$252,9450.0% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $22.6M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...